Differences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumonia.

PloS One
Anna de BreijMarie-Laure Joly-Guillou

Abstract

Despite many reports documenting its epidemicity, little is known on the interaction of Acinetobacter baumannii with its host. To deepen our insight into this relationship, we studied persistence of and host response to different A. baumannii strains including representatives of the European (EU) clones I-III in a mouse pneumonia model. Neutropenic mice were inoculated intratracheally with five A. baumannii strains and an A. junii strain and at several days morbidity, mortality, bacterial counts, airway inflammation, and chemo- and cytokine production in lungs and blood were determined. A. baumannii RUH875 and RUH134 (EU clone I and II, respectively) and sporadic strain LUH8326 resulted in high morbidity/mortality, whereas A. baumannii LUH5875 (EU clone III, which is less widespread than clone I and II) caused less symptoms. A. baumannii type strain RUH3023(T) and A. junii LUH5851 did not cause disease. All strains, except A. baumannii RUH3023(T) and A. junii LUH5851, survived and multiplied in the lungs for several days. Morbidity and mortality were associated with the severity of lung pathology and a specific immune response characterized by low levels of anti-inflammatory (IL-10) and specific pro-inflammatory (IL-12p40 and I...Continue Reading

References

Nov 1, 1996·The Journal of Infectious Diseases·T van der PollS F Lowry
Oct 24, 1998·Systematic and Applied Microbiology·L DijkshoornM Vaneechoutte
Apr 27, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·C WebsterH Humphreys
Oct 12, 2001·International Journal of Systematic and Evolutionary Microbiology·A NemecL Dijkshoorn
Jun 5, 2003·European Journal of Immunology·Aron J MednickArturo Casadevall
Aug 11, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Van LooverenUNKNOWN ARPAC Steering Group
Dec 21, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M E FalagasA Michalopoulos
Sep 15, 2005·The Journal of Experimental Medicine·Kyle I HappelJay K Kolls
Oct 8, 2005·American Journal of Respiratory and Critical Care Medicine·Sylvia KnappTom van der Poll
Nov 18, 2005·Trends in Immunology·Brent S McKenzieDaniel J Cua
Dec 6, 2005·Research in Microbiology·Je Chul LeeLenie Dijkshoorn
Sep 28, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R DobrewskiL Dijkshoorn
Jun 9, 2007·Expert Opinion on Biological Therapy·Ronan Kapetanovic, Jean-Marc Cavaillon
Jul 6, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J F TurtonT L Pitt
Nov 17, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H-W LeeJ Kim
Nov 17, 2007·Nature Reviews. Microbiology·Lenie DijkshoornHarald Seifert
Feb 18, 2009·FEMS Immunology and Medical Microbiology·Lauren B KingLarry S McDaniel
May 8, 2009·Journal of Microbiology and Biotechnology·Eui-Suk JeongYang-Kyu Choi
Sep 15, 2009·The Journal of Infection·Matthieu EveillardMarie-Laure Joly-Guillou
Aug 10, 2010·Journal of Proteomics·Chika C NwugoLuis A Actis
Nov 17, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P EspinalI Roca

❮ Previous
Next ❯

Citations

May 30, 2012·Cellular Microbiology·Brittany L Mortensen, Eric P Skaar
Apr 1, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Crystal L JonesEmil Lesho
Jun 3, 2016·Frontiers in Public Health·Saranya VijayakumarIndranil Biswas
Sep 1, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Amaro F Sanchez-LarrayozTomás Maira-Litrán
May 16, 2014·Journal of Clinical Microbiology·Nicholas A BeCrystal J Jaing
Dec 16, 2016·Clinical Microbiology Reviews·Darren WongBrad Spellberg
Apr 14, 2016·Antimicrobial Agents and Chemotherapy·Brian T TsujiJian Li
Jan 1, 2014·Pathogens and Disease·Luísa C S AntunesKevin J Towner
Oct 4, 2018·Frontiers in Microbiology·Hernán F PeñalozaSusan M Bueno
Mar 27, 2020·Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians·David G PereiraRenata A Casagrande
Aug 6, 2019·Frontiers in Microbiology·Faye C MorrisAnton Y Peleg
Sep 30, 2017·Frontiers in Cellular and Infection Microbiology·Grazieli MaboniSabine Tötemeyer
Oct 13, 2020·Frontiers in Cellular and Infection Microbiology·Wangxue Chen
Feb 23, 2021·Microbiological Research·Hing Jian MeaEng Hwa Wong

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.